A suspected case of Clostridium perfringens sepsis with intravascular hemolysis after transhepatic arterial chemoembolization: a case report

Table 2 Patients with intravascular hemolysis secondary to Clostridium perfringens sepsis after transhepatic arterial chemoembolization/transarterial embolization

Case	Reference	Year	Age	Sex	Tumor	Diameter	Liver cirrhosis	POD	Risk factor	ALT			Drug	Treatment	Outcome
Case	Reference	Year	Age	Sex	Tumor	Diameter	Liver cirrhosis	POD	Risk factor	Pre TACE	Post TACE	Hemolysis	Drug	Treatment	Outcome
1	[11]	1992	83	Male	HCC	115 mm		1		Normal range			Doxorubicin	Antibiotic	Dead
2	[12]	2010	74	Male	HCC			5	Gastrectomy				Epirubicin	Antibiotic Drainage	Survival
3	[12]	2011	70	Male	HCC	83 mm		2	ERBD	316			Epirubicin	Antibiotic Drainage	Dead
4	[13]	2014	71	Male	HCC	179 mm	+	2		145	1652	2312	5-fluorouracil Oxaliplatin	Antibiotic	Survival
5	Our case	2017	83	Male	HCC	40 mm	+	6	PPPD	76	120	362	Epirubicin	Antibiotic	Dead

ALT alanine aminotransferase, ERBD endoscopic retrograde biliary drainage, HCC hepatocellular carcinoma, POD postoperative day, PPPD pancreaticoduodenectomy, TACE transhepatic arterial chemoembolization

ISSN: 1752-1947